• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

ASTMH 2018

28 October - 1 November 2018

New Orleans, USA

67th Annual Meeting

The 67th American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting is designed for researchers, professors, government and public health officials, military personnel, travel clinic physicians, practicing physicians in tropical medicine, students and all health care providers working in the fields of tropical medicine, hygiene and global health. 

You can find DNDi at Booth #318!

Download DNDi @ ASTMH 2018

Symposia

From R&D to access for sleeping sickness elimination: Innovative public-private partnerships for new tools

Co-organized by Sanofi and DNDi

Date: Monday, 29 October 2018
Time: 19:15-21:15
Venue: Sheraton – Waterbury (2nd floor)

Chairs: Victor Kande Betu Kumeso, Ministry of Health, DRC, Luc Kuykens, Senior Vice President Global Health Programs, Sanofi, France & Bernard Pécoul, Executive Director, DNDi

An alternative model for drug development: The story of fexinidazole
Nathalie Strub-Wourgaft, NTD Director, DNDi, Geneva

Working in partnership for sleeping sickness elimination: Using new technologies
Florent Mbo, HAT Platform Coordinator, DRC (presenting on behalf of Eric Mwamba Miaka, Director National HAT Programme, DRC)

Finding every last case: The role of diagnostics in HAT elimination
Veerle Lejon, Research Director, Institut de Recherche pour le Développement (IRD), France

Importance of the development of an oral treatment for sleeping sickness through public-private partnership
Luc Kuykens, Senior Vice President Global Health Programs, Sanofi, France

Striving towards HAT elimination in South Sudan: An operational perspective
Laurence Flevaud, Operational Center Barcelona-Athens, MSF
Monitoring HAT elimination: Plans for validation
Gerardo Priotto, Department of Control of Neglected Tropical Diseases, WHO, Switzerland

 

Overcoming challenges in screening and diagnosis of Chagas disease

Date: Tuesday 30 October 2018
Time: 13:45-15:30
Venue: Sheraton – Oak Alley (4th Floor) / Sheraton – Waterbury (2nd floor)

Co-chairs: Sergio Sosa Estani, Head of Chagas Clinical Programme, DNDi Latin America & Colin Forsyth, Chagas Epidemiologist, DNDi North America

Differing responses to CD immunoassays: T. cruzi genetic diversity vs. host immune response
Claudia Herrera, Tulane University, New Orleans, USA

Latest developments in biomarkers research
Eric Chatelain, Head of Drug Discovery Programme, DNDi, Switzerland

Community-Based screening of Chagas disease in the USA: Boston’s Strong Hearts Program
Julia Koehler, Boston Children’s Hospital, Boston, USA

Implementation of a simplified diagnostic algorithm in an endemic area of Colombia
Colin Forsyth, Chagas Epidemiologist, DNDi North America

Oral presentations

Date: Sunday, 28 October 2018 & Monday, 29 October 2018
Time: 10:00-15:00 / 8:30-8:45
Venue: Sheraton – Waterbury (2nd floor)

The burden of skin disease and eye disease due to onchocerciasis in Africa for 1990, 2015 and 2025
Vinkeles Melchers NVS, Stolk WA, Remme JHF, Murdoch ME, Pedrique B, Bakker R, de Vlas SJ, Coffeng LE 

Date: Monday, 29 October 2018
Time: 15:00-15:15
Venue: Sheraton – Rhythms (2nd floor)

Novel 3-Dimensional Optical Scanning in the assessment of patients with mycetoma
Siddig E, Liberton N, van Eijnatten M, te Slaa S, Faroog A, Fahal AH, Wolff J, Zijlstra EE

Date: Wednesday, 31 October 2018
Time: 8:15-8:30
Venue: Sheraton – Rodrigue Gallery (1st floor)

Pharmacokinetic-pharmacodynamic assessment of the safety of fexinidazole for the treatment of human African trypanosomiasis
Watson J, Strub-Wourgraft N, Tarral A, Tarning J, White NJ

Date: Wednesday, 31 October 2018
Time: 9:30-9:45
Venue: Sheraton – Rodrigue Gallery (1st floor)

Modeling and simulations of fexinidazole treatment regiment for human African trypanosomia brucei gambiense trypanosomiasis (g-HAT) and their successful clinical application in adult and child patients
Gualano V, Felices M, Tarral A

Date: Thursday, 1 November 2018
Time: 10:30-10:45
Venue: Sheraton – Rodrigue Gallery (1st floor)

Oxfendazole treatment has a macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontisin vivo and inhibits Onchocerca gutturosa adult worm motility in vitro
Hübner MP, Martin C, Specht S, Koschel M, Dubben B, Frohberger SJ, Ehrens A, Fendler M, Struever D, Vallarino-Lhermitte N, Gokooi S, Townson S, Hoerauf A, Scandale I

Poster presentations

Date: Monday, 29 October 2018
Time: 12:00-13:45
Venue: Marriott – Grand Ballroom (3rd floor)

The Chagas disease study landscape: preliminary results of a systematic review of clinical and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform
Maguire BJ, Guérin PJ, Chatelain E, Sosa Estani S, Barreira F

A single-center, first-in-human, randomized, double-blind, placebo-controlled, parallel-group study to investigate the safety, tolerability and pharmacokinetics of escalating single doses of emodepside (BAY44-4400) in healthy male subjects
Gillon JYA, van den Berg F, Dequatre Cheeseman K, Hopchet N, Delhomme S, Peña Rossi C, Monnot F, Strub-Wourgaft N, Rodriguez ML, Don R.

Capacity Building Platform for clinical and operational research on human African trypanosomiasis
Mbo F, Valverde O

Date: Tuesday, 30 October 2018
Time: 12:00-13:45
Venue: Marriott – Grand Ballroom (3rd floor)

Prioritizing pathogens to support diagnostic product development for febrile illness management: a novel yet pragmatic approach
Roddy P, Osborn J, Roberts T, Guillen E, Bernal O, Ongarello S, Sprecher A, Page AL, Ribeiro I, Piriou E, Tamrat A, de la Tour R, Rao B, Flevaud L, Jensen T, McIver L, Kelly C, Dittrich S

Evaluation of point-of-care tests for visceral leishmaniasis diagnosis in Kenya
Mbuchi M, Ndung’u JM, Wasunna M, Osuna F, Magiri CG, Muia A, Kioko P, Bakari M, Mwathe F, Ronoh R, Abner E, Chirchir M, Njenga S, Kirigi G, Kimutai R, Cruz I

 

Date: Wednesday, 31 October 2018
Time: 12:00-13:45
Venue: Marriott – Grand Ballroom (3rd floor)

Determination of fexinidazole effect on QTc in healthy volunteers and human African Trypanosomia brucei gambiense trypanosomiasis(g-HAT) patients using concentration-response modelling
Tarral A, Felices M, Voirot P

Sequential versus classical designs for early phase drug trials against visceral leishmaniasis
Alexander ND, Alves F, Balasegaram M, Blesson S, Burza S, Edwards T, Omollo R, Wasunna M

More information:

  • Event website
  • Programme

Other events

Loading...
15-20 June 2025

Kigali, Rwanda

Twelfth EDCTP Forum

15-18 June 2025

Manila, Philippines

8th Asia Dengue Summit

22 May 2025

Online event

MSF Scientific Days

21 May 2025, 9-10:30 AM

Geneva, Switzerland

Scaling impact: Climate & health solutions that drive change

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License